mRNA |
SNS-032 |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.08 |
0.1 |
mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.1 |
mRNA |
KU-0063794 |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.1 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.1 |
mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.1 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.1 |
mRNA |
sitagliptin |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.1 |